Authors : Rohit R Doke, Aditi R Lende, Shweta S Mule, Mrunal S Mahajan, Pranali Kulawade, Gayatri V Korde, Rutuja B Bhand
DOI : 10.18231/j.ijcaap.2023.014
Volume : 8
Issue : 2
Year : 2023
Page No : 80-85
The most prevalent gynecologic disease is cancer of the endometrium, In the US, it is the fourth most prevalent malignancy in women after breast, lung, and colorectal malignancies. Despite a steady prevalence of sickness, during the past 20 years, the death rate has climbed by more than 100%. The risk factors of endometrial cancer includes unopposed estrogen therapy, early menarche, late menopause, tamoxifen therapy, nulliparity, infertility or inability to ovulate, and polycystic ovarian syndrome. Ageing, obesity, hypertension, diabetes mellitus, and genetic nonpolyposis colorectal cancer are additional risk factors. This article presents an overview of endometrial carcinoma's epidemiology, prevention, diagnosis, therapy, and prognosis. Chemotherapy, radiation, surgery, and radiation therapy are all forms of treatment. Nonsurgical treatments can be used to treat endometrial hyperplasia with a low to moderate risk. The likelihood of survival is often determined by the disease stage and histology, with the majority of patients at stages I and II having a good prognosis. Endometrial cancer may be prevented in part by managing risk factors such obesity, diabetes, and hypertension.
Keywords: Chemotherapy, Management of EC, Pathophysiology, Surgical treatment